NEDA was evaluated as the proportion of patients free of relapses, 3-month confirmed disability progression, and free of new or newly enlarging T2 lesion and Gadolinium enhancing lesions.
https://ift.tt/2UX86va
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
The development of sweet taste: From biology to hedonics. Rev Endocr Metab Disord. 2016 May 19; Authors: Mennella JA, Bobowski NK, Re...
-
Abstract Purpose Benzodiazepines are effective medicines for insomnia and anxiety but are commonly used beyond recommended treatment time ...
-
Related Articles BioBits™ Explorer: A modular synthetic biology education kit. Sci Adv. 2018 Aug;4(8):eaat5105 Authors: Huang A, Ngu...
-
Publication date: Available online 2 August 2017 Source: International Journal of Radiation Oncology*Biology*Physics Author(s): Mark R. Wa...
-
Albumin Might Attenuate Bacteria-Induced Damage on Kupffer Cells for Patients with Chronic Liver Disease Hao Lin et al. The TGF-β/NA... -
Abstract Background Infants with acute lymphoblastic leukemia (ALL) treated with high-dose methotrexate may have reduced methotrexate cl...
-
Abstract Gait is a novel biometric feature that offers human identification at a distance and without physical interaction with the imagin...
-
Related Articles Oleogustus: The Unique Taste of Fat. Chem Senses. 2015 Sep;40(7):507-16 Authors: Running CA, Craig BA, Mattes RD A...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου